‘I thought I had injured my back – but it was incurable blood cancer’ More than 33,000 people in the UK are living with myeloma, a type of incurable blood cancer that causes bone pain The Independent UK · Sep 13, 2025
Dad diagnosed with stage 4 cancer after wife’s death from the illness Paul Garratt lost his wife of 10 years to breast cancer in 2015 at the age of 31 The Independent UK · Sep 12, 2025
Regeneron's Libtayo Combo Achieves Nearly Double Survival Rate In Advanced Lung Cancer Compared To Chemotherapy Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Tuesday announced five-year follow-up results on overall survival (OS) from the Phase 3 EMPOWER-Lung 3 trial of Libtayo (cemiplimab) plus platinum-based chemotherapy versus chemotherapy alone as a first-line treatment for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with no EGFR, ALK,… Benzinga · Sep 9, 2025
BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy BioNTech SE (NASDAQ:BNTX) and Bristol Myers Squibb Co (NYSE:BMY) shared interim Phase 2 data on pumitamig (BNT327/BMS986545) plus chemotherapy in patients with untreated extensive-stage small cell lung cancer (ES-SCLC). Benzinga · Sep 8, 2025
AstraZeneca Lung Cancer Combo Extends Patient Survival By Years In Key Study On Sunday, AstraZeneca Plc (AZN) released results from the final overall survival (OS) analysis of the FLAURA2 Phase 3 trial in previously untreated patients with locally advanced (Stage IIIB-IIIC) or metastatic (Stage IV) non-small cell lung cancer (NSCLC) whose tumors have EGFR exon 19 deletion or exon 21 L858R mutations. Benzinga · Sep 8, 2025
Summit Therapeutics' Lung Cancer Drug Under Dark Clouds As Keytruda Challenger Shows Regional Data Differences Summit Therapeutics Inc. (NASDAQ:SMMT), on Sunday, revealed the updated overall survival (OS) results from the global Phase 3 HARMONi trial of ivonescimab at the 2025 World Conference on Lung Cancer (WCLC). Benzinga · Sep 8, 2025
BioNTech Advances On Positive Phase 3 Breast Cancer Drug Data On Friday, BioNTech SE (NASDAQ:BNTX) and its partner Duality Biologics (Suzhou) Co., Ltd. released topline data from a Phase 3 trial in China evaluating trastuzumab pamirtecan (BNT323/DB-1303) versus trastuzumab emtansine (T-DM1) for HER2-positive unresectable or metastatic breast cancer patients who have previously received trastuzumab and a taxane-based chemotherapy. Benzinga · Sep 5, 2025
Amgen Faces Setback As Final Data Weakens Case For Gastric Cancer Drug On Wednesday, Amgen Inc. (NASDAQ:AMGN) and its partner Zai Lab (NASDAQ:ZLAB) said the final analysis of the Phase 3 FORTITUDE-101 trial evaluating bemarituzumab in combination with chemotherapy (mFOLFOX6) in first-line gastric cancer has been completed. Benzinga · Sep 4, 2025
Dermot Murnaghan ‘feeling pretty good’ after chemotherapy for stage four cancer The TV presenter, who has been diagnosed with prostate cancer, said men should demand testing on the NHS. Evening Standard · Aug 27, 2025
Why do some people grow 'chemo curls' after cancer treatment? After chemotherapy, some people get "chemo curls" and other changes to their hair texture and appearance. But why? LiveScience · Aug 17, 2025
Mini hearts to save cancer survivors from heart disease Lab-grown "mini hearts" the size of a grain of sand are being used to test new drugs researchers hope will protect breast cancer patients from heart failure. AAP · Aug 16, 2025
How Designing Supercars Helped Gordon Murray Through Cancer Gordon Murray can’t stop working. As he approaches 80 years old, Murray is still developing new supercars, and not even a cancer diagnosis took him away from the drafting table. One of Gordon Murray Automotive’s newest supercars—the S1 LM—was developed while its namesake was undergoing chemotherapy. Motor1 · Aug 15, 2025
Woman diagnosed with same cancer as late husband after stomach ache Ann Lally and her late husband, Mike, were both diagnosed with advanced pancreatic cancer The Independent UK · Aug 14, 2025
Parents who advised daughter against chemotherapy warned over inquest behaviour Paloma Shemirani, 23, collapsed last July and was taken to hospital where she died five days later having earlier declined cancer treatment. Evening Standard · Aug 12, 2025
Benzinga · Aug 12, 2025 Merck, Pfizer-Backed Therapy Improves Outcomes For Cisplatin-Ineligible Bladder Cancer Patients On Tuesday, Merck Co. Inc. (NYSE:MRK) released topline results from the Phase 3 KEYNOTE-905 trial (also known as EV-303) in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-based chemotherapy.
Evening Standard · Aug 10, 2025 New drug ‘could boost effectiveness of chemotherapy’, developers say It is hoped KCL-HO-1i can be trialled on humans, with researchers suggesting it could one day be a ‘valuable companion drug’ to chemotherapy.
The Independent UK · Aug 10, 2025 The new take-at-home drug that ‘could boost effectiveness of chemotherapy’ New medicine will spare some patients from more aggressive treatments
International Business Times · Aug 7, 2025 Secondhand Chemo Is Real: How Jim Mullowney Is Dealing With ChemWaste Crisis From Both People and Business Point of View At the center of Pharma-Cycle's innovation is a patented packaging system designed to safely collect and manage human waste contaminated by chemotherapy drugs, waste that continues to emit cytotoxic chemicals long after a patient leaves the clinic.
The Fashion Central · Jul 31, 2025 A Mother’s Influence and a Daughter’s Death: The Story of Paloma Shemirani A University of Cambridge graduate who tragically passed away after refusing chemotherapy for non-Hodgkin lymphoma told a court she was anti-vax
The Independent UK · Jul 30, 2025 Twin brother of woman who refused chemotherapy says mother ‘sacrificed’ her daughter Paloma Shemirani, 23, died 2024, after declining the treatment for non-Hodgkin lymphoma
Evening Standard · Jul 30, 2025 Brother of woman who refused chemotherapy says mother ‘sacrificed’ her daughter Paloma Shemirani, 23, died at Royal Sussex County Hospital on July 24 2024, after declining the treatment for non-Hodgkin lymphoma.
Bored Panda · Jul 29, 2025 23YO ‘Anti-Vax’ Woman Passes Away After Refusing Chemotherapy As Brother Blames Mom "She didn't believe she had cancer"
The Conversation · Jul 25, 2025 Unlocking nature’s toolkit: how plant compounds may support cancer therapy Green tea and red wine may seem like simple dietary choices – but beneath the surface, they harbour compounds with remarkable medical potential. Scientists are uncovering how these everyday drinks might support cancer treatment, not by replacing conventional therapies like chemotherapy or radiotherapy, but by enhancing their effectiveness and reducing…
Benzinga · Jul 21, 2025 AstraZeneca's Multi-Billion Dollar Cancer Drug Tagrisso Improves Overall Survival In Patients With Advanced Lung Cancer On Monday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the final overall survival (OS) analysis of the FLAURA2 Phase 3 trial of Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy.
The Independent UK · Jul 18, 2025 Doctor concerned mother influenced daughter’s cancer treatment, inquest hears Cambridge graduate Paloma Shemirani refused chemotherapy after being diagnosed in December 2023